Delivery Order SPE2DR25D1017-SPE2DR26F9CJV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,401.50 to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no...
- The Defense Logistics Agency awarded a delivery order valued at $9,948.80 to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products, with an ultimate completion date of September 23, 2025. This firm fixed-price, non-set-aside contract was awarded on September 22, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,550.16 by the Defense Logistics Agency on November 4, 2025, with completion scheduled for November 5, 2025. The delivery order, designated as AMLOD-VALSA-HCTZ 5-160-12.5 MG 30S, pertains to pharmaceutical products and represents a firm fixed-price, competitively awarded contract with no set-aside designation. This award is issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,773.34, is a delivery order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The Defense Logistics Agency (DLA) awarded a $19,138.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. The contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a...
- The Defense Logistics Agency awarded a delivery order valued at $13,904.53 to AmerisourceBergen Drug Corp for the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG 30S, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The product is a combination antihypertensive medication containing amlodipine, valsartan,...
- This $4,759.35 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract provides for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product, with a completion date of August 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' healthcare...
- This delivery order, awarded June 3, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, represents a firm fixed-price pharmaceutical supply contract valued at $2,975.18. The order calls for delivery of AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-tablet supply to the vendor's location in Conshohocken, Pennsylvania, with completion scheduled for June 4, 2025. The contract was awarded without set-aside designation through competitive procurement, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical products under contract number 4569986643, with an award date of November 12, 2025, and a ceiling value of $3,987.86. The specific delivery consists of AMLOD-VALSA-HCTZ 5-160-12.5 mg tablets (30-count supply), a combination antihypertensive medication used to treat high blood pressure. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,217.22 to AmerisourceBergen Drug Corp for VALSAR-HCTZ 320-25 90S pharmaceutical products, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CJVDelivery Order
The Defense Logistics Agency awarded a $2,231.38 delivery order to AmerisourceBergen Drug Corp for AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical product on January 2, 2026, with completion targeted for January 5, 2026. This non-set-aside, firm fixed price delivery order was performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a significant federal contract portfolio predominantly with the Defense Logistics Agency's Medical Supply Chain. The company supplies an extensive range of medical commodities including brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government entities. All reviewed contract awards demonstrate the company's capability to meet federal procurement requirements through open competition, with delivery orders featuring firm fixed pricing and transaction values ranging from under $100 to exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/1/26 |